263 related articles for article (PubMed ID: 24580828)
1. The role of donor-specific HLA alloantibodies in liver transplantation.
O'Leary JG; Demetris AJ; Friedman LS; Gebel HM; Halloran PF; Kirk AD; Knechtle SJ; McDiarmid SV; Shaked A; Terasaki PI; Tinckam KJ; Tomlanovich SJ; Wood KJ; Woodle ES; Zachary AA; Klintmalm GB
Am J Transplant; 2014 Apr; 14(4):779-87. PubMed ID: 24580828
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
3. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
4. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
5. Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients.
Levitsky J; Kaneku H; Jie C; Walsh RC; Abecassis M; Tambur AR
Am J Transplant; 2016 Aug; 16(8):2437-44. PubMed ID: 26896194
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
Cuadrado A; San Segundo D; López-Hoyos M; Crespo J; Fábrega E
World J Gastroenterol; 2015 Oct; 21(39):11016-26. PubMed ID: 26494958
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
8. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
9. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver.
Abu-Elmagd KM; Wu G; Costa G; Lunz J; Martin L; Koritsky DA; Murase N; Irish W; Zeevi A
Am J Transplant; 2012 Nov; 12(11):3047-60. PubMed ID: 22947059
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.
Zhang Q; Hickey M; Drogalis-Kim D; Zheng Y; Gjertson D; Cadeiras M; Khuu T; Baas AS; Depasquale EC; Halnon NJ; Perens G; Alejos J; Cruz D; Ali N; Shemin R; Kwon M; Fishbein MC; Ardehali A; Deng M; Reed EF
Transplantation; 2018 Oct; 102(10):e431-e438. PubMed ID: 29916988
[TBL] [Abstract][Full Text] [Related]
11. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
Kwon H; Kim YH; Choi JY; Shin S; Jung JH; Park SK; Han DJ
Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
[TBL] [Abstract][Full Text] [Related]
12. De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study.
Kovandova B; Slavcev A; Honsova E; Erhartova D; Skibova J; Viklicky O; Trunecka P
Transpl Int; 2020 Dec; 33(12):1799-1806. PubMed ID: 33020979
[TBL] [Abstract][Full Text] [Related]
13. Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature.
Wozniak LJ; Naini BV; Hickey MJ; Bhattacharyya S; Reed EF; Busuttil RW; Farmer DG; Vargas JH; Venick RS; McDiarmid SV
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27597379
[TBL] [Abstract][Full Text] [Related]
14. Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients.
Kincaide E; Hitchman K; Hall R; Yamaguchi I; Ding Y; Crowther B
Pediatr Transplant; 2019 Dec; 23(8):e13590. PubMed ID: 31617318
[TBL] [Abstract][Full Text] [Related]
15. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
16. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
[TBL] [Abstract][Full Text] [Related]
17. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
[TBL] [Abstract][Full Text] [Related]
18. Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation.
Hassan S; Regan F; Brown C; Harmer A; Anderson N; Beckwith H; Roufosse CA; Santos-Nunez E; Brookes P; Taube D; Willicombe M
Am J Transplant; 2019 Jun; 19(6):1720-1729. PubMed ID: 30582278
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
[TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'.
Kim PT; Demetris AJ; O'Leary JG
Curr Opin Organ Transplant; 2016 Apr; 21(2):209-18. PubMed ID: 26918881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]